Rowlandmiller & Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.45M | Sell |
45,500
-64
| -0.1% | -$11.9K | 1.74% | 15 |
|
|
2025
Q1 | $9.55M | Sell |
45,564
-1,695
| -4% | -$355K | 2.01% | 15 |
|
|
2024
Q4 | $8.4M | Buy |
47,259
+35
| +0.1% | +$6.22K | 1.76% | 16 |
|
|
2024
Q3 | $9.33M | Buy |
47,224
+535
| +1% | +$106K | 1.89% | 15 |
|
|
2024
Q2 | $8.01M | Sell |
46,689
-90
| -0.2% | -$15.4K | 1.75% | 15 |
|
|
2024
Q1 | $8.52M | Sell |
46,779
-250
| -0.5% | -$45.5K | 1.8% | 17 |
|
|
2023
Q4 | $7.29M | Sell |
47,029
-288
| -0.6% | -$44.6K | 1.67% | 18 |
|
|
2023
Q3 | $7.05M | Sell |
47,317
-233
| -0.5% | -$34.7K | 1.74% | 18 |
|
|
2023
Q2 | $6.41M | Sell |
47,550
-404
| -0.8% | -$54.4K | 1.51% | 21 |
|
|
2023
Q1 | $7.64M | Buy |
47,954
+356
| +0.7% | +$56.7K | 1.86% | 16 |
|
|
2022
Q4 | $7.73M | Sell |
47,598
-320
| -0.7% | -$52K | 1.91% | 18 |
|
|
2022
Q3 | $6.43M | Buy |
47,918
+641
| +1% | +$86K | 1.73% | 21 |
|
|
2022
Q2 | $7.24M | Sell |
47,277
-170
| -0.4% | -$26K | 1.85% | 19 |
|
|
2022
Q1 | $7.69M | Sell |
47,447
-8,529
| -15% | -$1.38M | 1.79% | 18 |
|
|
2021
Q4 | $6.48M | Buy |
55,976
+54,533
| +3,779% | +$6.32M | 1.45% | 22 |
|
|
2021
Q3 | $142K | Sell |
1,443
-40,710
| -97% | -$4M | 0.05% | 134 |
|
|
2021
Q2 | $4.75M | Buy |
42,153
+2,620
| +7% | +$295K | 1.17% | 29 |
|
|
2021
Q1 | $4.28M | Buy |
39,533
+38,090
| +2,640% | +$4.12M | 1.12% | 29 |
|
|
2020
Q4 | $155K | Sell |
1,443
-62
| -4% | -$6.64K | 0.04% | 145 |
|
|
2020
Q3 | $115K | Buy |
1,505
+62
| +4% | +$4.72K | 0.05% | 140 |
|
|
2020
Q2 | $142K | Sell |
1,443
-62
| -4% | -$6.09K | 0.05% | 134 |
|
|
2020
Q1 | $115K | Buy |
1,505
+100
| +7% | +$7.62K | 0.05% | 140 |
|
|
2019
Q4 | $124K | Buy |
+1,405
| New | +$124K | 0.04% | 140 |
|